These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
4. Emerging Therapies and Therapeutic Targets for Composite Liver Disease: NASH. Sobhia ME; Kumari S; Kumar H; Gandhe A; Kaushik D; Kumar H; Jain J; Ankita ; Mallick M; Pavani B; Moudgil M; Patel D Curr Top Med Chem; 2023; 23(21):2027-2047. PubMed ID: 37455455 [TBL] [Abstract][Full Text] [Related]
5. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. Brown E; Hydes T; Hamid A; Cuthbertson DJ Clin Ther; 2021 Sep; 43(9):1476-1504. PubMed ID: 34446271 [TBL] [Abstract][Full Text] [Related]
6. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease. Lai J; Wang HL; Zhang X; Wang H; Liu X Arch Pathol Lab Med; 2022 Aug; 146(8):940-946. PubMed ID: 34871361 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M Gene; 2020 Jun; 742():144549. PubMed ID: 32184169 [TBL] [Abstract][Full Text] [Related]
8. Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Hirsova P; Bamidele AO; Wang H; Povero D; Revelo XS Front Endocrinol (Lausanne); 2021; 12():760860. PubMed ID: 34777255 [TBL] [Abstract][Full Text] [Related]
9. An Obesogenic Dietary Mouse Model of Nonalcoholic Steatohepatitis. Zarrouki B; Boucher J Methods Mol Biol; 2020; 2164():121-127. PubMed ID: 32607889 [TBL] [Abstract][Full Text] [Related]
10. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Lee C; Kim J; Jung Y Cells; 2019 Oct; 8(10):. PubMed ID: 31619023 [TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH). Ota T Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745 [TBL] [Abstract][Full Text] [Related]
13. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA; Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292 [TBL] [Abstract][Full Text] [Related]
15. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M; Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100 [TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Cusi K Diabetologia; 2016 Jun; 59(6):1112-20. PubMed ID: 27101131 [TBL] [Abstract][Full Text] [Related]
17. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Chow MD; Lee YH; Guo GL Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273 [TBL] [Abstract][Full Text] [Related]
18. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Hwang S; Yun H; Moon S; Cho YE; Gao B Front Endocrinol (Lausanne); 2021; 12():751802. PubMed ID: 34707573 [TBL] [Abstract][Full Text] [Related]
19. Current Options and Future Directions for NAFLD and NASH Treatment. Zhang C; Yang M Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299189 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis. Esteban JPG; Asgharpour A Gastroenterol Clin North Am; 2020 Mar; 49(1):105-121. PubMed ID: 32033758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]